William Blair & Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $288K | Buy |
5,232
+432
| +9% | +$23.7K | ﹤0.01% | 1284 |
|
|
2025
Q1 | $339K | Sell |
4,800
-27,542
| -85% | -$1.95M | ﹤0.01% | 1209 |
|
|
2024
Q4 | $2.13M | Sell |
32,342
-2,174
| -6% | -$143K | 0.01% | 700 |
|
|
2024
Q3 | $2.43M | Sell |
34,516
-2,318
| -6% | -$163K | 0.01% | 657 |
|
|
2024
Q2 | $3.03M | Sell |
36,834
-953
| -3% | -$78.5K | 0.01% | 593 |
|
|
2024
Q1 | $3.3M | Buy |
37,787
+878
| +2% | +$76.7K | 0.01% | 568 |
|
|
2023
Q4 | $3.56M | Sell |
36,909
-490
| -1% | -$47.2K | 0.01% | 538 |
|
|
2023
Q3 | $3.31M | Buy |
37,399
+552
| +1% | +$48.8K | 0.01% | 528 |
|
|
2023
Q2 | $3.19M | Buy |
36,847
+299
| +0.8% | +$25.9K | 0.01% | 549 |
|
|
2023
Q1 | $3.55M | Sell |
36,548
-3,710
| -9% | -$361K | 0.01% | 516 |
|
|
2022
Q4 | $4.17M | Sell |
40,258
-40
| -0.1% | -$4.14K | 0.02% | 461 |
|
|
2022
Q3 | $3.42M | Sell |
40,298
-2,527
| -6% | -$214K | 0.02% | 498 |
|
|
2022
Q2 | $3.55M | Buy |
42,825
+1,655
| +4% | +$137K | 0.02% | 499 |
|
|
2022
Q1 | $3.17M | Buy |
41,170
+559
| +1% | +$43.1K | 0.01% | 579 |
|
|
2021
Q4 | $3.59M | Sell |
40,611
-3,029
| -7% | -$268K | 0.01% | 569 |
|
|
2021
Q3 | $3.37M | Sell |
43,640
-1,875
| -4% | -$145K | 0.01% | 557 |
|
|
2021
Q2 | $3.8M | Sell |
45,515
-1,350
| -3% | -$113K | 0.01% | 528 |
|
|
2021
Q1 | $3.54M | Sell |
46,865
-19,669
| -30% | -$1.49M | 0.01% | 534 |
|
|
2020
Q4 | $5.83M | Sell |
66,534
-10,978
| -14% | -$963K | 0.02% | 406 |
|
|
2020
Q3 | $5.9M | Sell |
77,512
-11,950
| -13% | -$909K | 0.03% | 364 |
|
|
2020
Q2 | $11M | Buy |
89,462
+4,983
| +6% | +$615K | 0.05% | 253 |
|
|
2020
Q1 | $7.14M | Buy |
84,479
+4,310
| +5% | +$364K | 0.04% | 273 |
|
|
2019
Q4 | $6.78M | Buy |
80,169
+2,678
| +3% | +$226K | 0.03% | 332 |
|
|
2019
Q3 | $5.22M | Sell |
77,491
-10,585
| -12% | -$713K | 0.03% | 366 |
|
|
2019
Q2 | $7.54M | Buy |
88,076
+4,587
| +5% | +$393K | 0.04% | 305 |
|
|
2019
Q1 | $7.42M | Buy |
83,489
+4,020
| +5% | +$357K | 0.05% | 299 |
|
|
2018
Q4 | $6.77M | Buy |
79,469
+141
| +0.2% | +$12K | 0.05% | 287 |
|
|
2018
Q3 | $7.69M | Sell |
79,328
-205
| -0.3% | -$19.9K | 0.05% | 295 |
|
|
2018
Q2 | $7.49M | Sell |
79,533
-4,455
| -5% | -$420K | 0.05% | 277 |
|
|
2018
Q1 | $6.81M | Sell |
83,988
-9,825
| -10% | -$797K | 0.05% | 293 |
|
|
2017
Q4 | $8.37M | Sell |
93,813
-1,438
| -2% | -$128K | 0.06% | 262 |
|
|
2017
Q3 | $8.87M | Sell |
95,251
-2,289
| -2% | -$213K | 0.07% | 245 |
|
|
2017
Q2 | $8.86M | Sell |
97,540
-2,421
| -2% | -$220K | 0.07% | 250 |
|
|
2017
Q1 | $8.79M | Sell |
99,961
-581
| -0.6% | -$51.1K | 0.07% | 244 |
|
|
2016
Q4 | $8.33M | Sell |
100,542
-5,670
| -5% | -$470K | 0.07% | 235 |
|
|
2016
Q3 | $9.83M | Sell |
106,212
-4,346
| -4% | -$402K | 0.09% | 217 |
|
|
2016
Q2 | $8.6M | Sell |
110,558
-1,533
| -1% | -$119K | 0.08% | 219 |
|
|
2016
Q1 | $9.24M | Sell |
112,091
-10,447
| -9% | -$862K | 0.09% | 206 |
|
|
2015
Q4 | $12.8M | Sell |
122,538
-47,221
| -28% | -$4.95M | 0.12% | 185 |
|
|
2015
Q3 | $17.9M | Sell |
169,759
-1,071,548
| -86% | -$113M | 0.15% | 159 |
|
|
2015
Q2 | $170M | Sell |
1,241,307
-461,550
| -27% | -$63.1M | 0.25% | 110 |
|
|
2015
Q1 | $212M | Sell |
1,702,857
-999,732
| -37% | -$125M | 0.33% | 76 |
|
|
2014
Q4 | $244M | Buy |
2,702,589
+612,635
| +29% | +$55.4M | 0.39% | 43 |
|
|
2014
Q3 | $151M | Sell |
2,089,954
-111,317
| -5% | -$8.03M | 0.26% | 105 |
|
|
2014
Q2 | $137M | Sell |
2,201,271
-210,442
| -9% | -$13.1M | 0.22% | 140 |
|
|
2014
Q1 | $165M | Sell |
2,411,713
-224,536
| -9% | -$15.3M | 0.27% | 103 |
|
|
2013
Q4 | $185M | Buy |
2,636,249
+532,886
| +25% | +$37.5M | 0.31% | 82 |
|
|
2013
Q3 | $152M | Buy |
2,103,363
+292,529
| +16% | +$21.1M | 0.27% | 98 |
|
|
2013
Q2 | $101M | Buy |
+1,810,834
| New | +$101M | 0.2% | 149 |
|